Clinical Significance of Galectin-7 in Epithelial Ovarian Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ha-Jeong | - |
dc.contributor.author | Jeon, Hye-Kyung | - |
dc.contributor.author | Lee, Jae-Kwan | - |
dc.contributor.author | Sung, Chang Ohk | - |
dc.contributor.author | Do, In-Gu | - |
dc.contributor.author | Choi, Chel Hun | - |
dc.contributor.author | Kim, Tae-Joong | - |
dc.contributor.author | Kim, Byoung-Gie | - |
dc.contributor.author | Bae, Duk-Soo | - |
dc.contributor.author | Lee, Jeong-Won | - |
dc.date.accessioned | 2021-09-06T03:12:04Z | - |
dc.date.available | 2021-09-06T03:12:04Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/103673 | - |
dc.description.abstract | Background: Galectin-7 (GAL-7) has been highlighted as an important marker in many types of cancers by either inhibiting or promoting tumor growth. In this novel study, we assessed the association of GAL-7 with clinicopathological variables and survival outcomes in epithelial ovarian cancer (EOC) and investigated the role of GAL-7 in proliferation of ovarian cancer cell lines. Materials and Methods: The expression of GAL-7 was determined in 63 formalin-fixed, paraffin-embedded EOC tissues using an immunohistochemical method and we compared various associated clinicopathological factors. To evaluate the role of GAL-7 in cell proliferation, we performed proliferation assays with GAL-7 siRNA using ovarian cancer cell lines, including A2780-PAR cells. Results: Immunohistochemical analysis revealed that GAL-7 expression was primarily detected in nuclei and occasionally in the nucleus and cytoplasm. High GAL-7 expression was associated with greater age (p=0.016), high mortality (p=0.025), and poor overall survival outcome (p=0.029). In addition, the residual tumor volume was larger in the high-expression group compared to the low-expression group, although the difference was not statistically significant (p=0.059). Down-regulation of GAL-7 using siRNA resulted in the inhibition of cell proliferation of A2780-PAR cells. Conclusion: We observed that high GAL-7 might be associated with poor survival outcome in patients with EOC, and may be fitnctionally involved in cell proliferation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.subject | SQUAMOUS-CELL CARCINOMAS | - |
dc.subject | HYPOPHARYNGEAL CANCER | - |
dc.subject | P53-INDUCED GENE-1 | - |
dc.subject | TUMOR PROGRESSION | - |
dc.subject | EXPRESSION | - |
dc.subject | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject | IDENTIFICATION | - |
dc.subject | PROLIFERATION | - |
dc.subject | TUMORIGENESIS | - |
dc.subject | ACCUMULATION | - |
dc.title | Clinical Significance of Galectin-7 in Epithelial Ovarian Cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Jae-Kwan | - |
dc.identifier.scopusid | 2-s2.0-84876770036 | - |
dc.identifier.wosid | 000317632200036 | - |
dc.identifier.bibliographicCitation | ANTICANCER RESEARCH, v.33, no.4, pp.1555 - 1561 | - |
dc.relation.isPartOf | ANTICANCER RESEARCH | - |
dc.citation.title | ANTICANCER RESEARCH | - |
dc.citation.volume | 33 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1555 | - |
dc.citation.endPage | 1561 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMAS | - |
dc.subject.keywordPlus | HYPOPHARYNGEAL CANCER | - |
dc.subject.keywordPlus | P53-INDUCED GENE-1 | - |
dc.subject.keywordPlus | TUMOR PROGRESSION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | TUMORIGENESIS | - |
dc.subject.keywordPlus | ACCUMULATION | - |
dc.subject.keywordAuthor | Galectin-7 | - |
dc.subject.keywordAuthor | ovarian cancer | - |
dc.subject.keywordAuthor | siRNA | - |
dc.subject.keywordAuthor | prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.